|
|
||||||||
From the Geriatric Research, Education, and Clinical Centers (Drs. Craft, Peskind, and Schellenberg), Mental Health Service (Drs. Peskind and Raskind), and Department of Medicine (Drs. Schwartz and Porte), Veteran Affairs Puget Sound Health Care System, Seattle, WA; and the Departments of Psychiatry and Behavioral Sciences (Drs. Craft, Peskind, and Raskind), Medicine (Drs. Schwartz and Porte), Pharmacology (Dr. Schellenberg), and Neurology (Dr. Schellenberg), University of Washington School of Medicine, Seattle, WA.
Address correspondence and reprint requests to Dr. Suzanne Craft, GRECC 182B, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA 98108.
Patients with Alzheimer's disease (AD) have elevations of fasting plasma insulin that are hypothesized to be associated with disrupted brain insulin metabolism. We examined paired fasted plasma and CSF insulin levels in 25 patients with AD and 14 healthy age-matched adults and determined whether insulin levels were related to severity of dementia and apolipoprotein E-
4 homozygosity, a known genetic risk factor for AD. The AD patients had lower CSF insulin, higher plasma insulin, and a reduced CSF-to-plasma insulin ratio when compared with healthy adults. The differences were greater for patients with more advanced AD. Patients who were not apolipoprotein E-
4 homozygotes had higher plasma insulin levels and reduced CSF-to-plasma ratios, whereas
4 homozygotes with AD had normal values. Both plasma and CSF insulin levels are abnormal in AD, and there are metabolic differences among apolipoprotein E genotypes.
Supported by the Department of Veteran Affairs, National Institute of Aging grants AG-10880 (to S.C.), AG-08419 (to M.R.), and AG-05136 (to M.R., E.P., and G.D.S.), Alzheimer's Association IIRG-95-1151 (to S.C.), NS 32273(to M.S.), and DK 12829 (to M.S. and D.P.).
Received March 17, 1997. Accepted in final form July 23, 1997.
This article has been cited by other articles:
![]() |
C. T. Kodl and E. R. Seaquist Cognitive Dysfunction and Diabetes Mellitus Endocr. Rev., June 1, 2008; 29(4): 494 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Reger, G. S. Watson, P. S. Green, C. W. Wilkinson, L. D. Baker, B. Cholerton, M. A. Fishel, S. R. Plymate, J.C.S. Breitner, W. DeGroodt, et al. Intranasal insulin improves cognition and modulates {beta}-amyloid in early AD Neurology, February 5, 2008; 70(6): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W. H. Yu, J. A. Luchsinger, B. Wadzinski, K. E. Duff, et al. Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms J. Neurosci., December 12, 2007; 27(50): 13635 - 13648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Burns, J. E. Donnelly, H. S. Anderson, M. S. Mayo, L. Spencer-Gardner, G. Thomas, B. B. Cronk, Z. Haddad, D. Klima, D. Hansen, et al. Peripheral insulin and brain structure in early Alzheimer disease Neurology, September 11, 2007; 69(11): 1094 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Daubert, M.-Y. Chung, and V. L. Brooks Insulin resistance and impaired baroreflex gain during pregnancy Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2188 - R2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Clodfelder-Miller, A. A. Zmijewska, G. V.W. Johnson, and R. S. Jope Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency Diabetes, December 1, 2006; 55(12): 3320 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao, B. Teter, T. Morihara, G. P. Lim, S. S. Ambegaokar, O. J. Ubeda, S. A. Frautschy, and G. M. Cole Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention J. Neurosci., December 8, 2004; 24(49): 11120 - 11126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peila, B. L. Rodriguez, L. R. White, and L. J. Launer Fasting insulin and incident dementia in an elderly population of Japanese-American men Neurology, July 27, 2004; 63(2): 228 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cummings Alzheimer's Disease N. Engl. J. Med., July 1, 2004; 351(1): 56 - 67. [Full Text] [PDF] |
||||
![]() |
A. M. Kanaya, E. Barrett-Connor, G. Gildengorin, and K. Yaffe Change in Cognitive Function by Glucose Tolerance Status in Older Adults: A 4-Year Prospective Study of the Rancho Bernardo Study Cohort Arch Intern Med, June 28, 2004; 164(12): 1327 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function Arch Neurol, May 1, 2004; 61(5): 661 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rasgon and L. Jarvik Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2004; 59(2): M178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Watson, E. R. Peskind, S. Asthana, K. Purganan, C. Wait, D. Chapman, M. W. Schwartz, S. Plymate, and S. Craft Insulin increases CSF A{beta}42 levels in normal older adults Neurology, June 24, 2003; 60(12): 1899 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Cook, J. B. Leverenz, P. J. McMillan, J. J. Kulstad, S. Ericksen, R. A. Roth, G. D. Schellenberg, L.-W. Jin, K. S. Kovacina, and S. Craft Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-{epsilon}4 Allele Am. J. Pathol., January 1, 2003; 162(1): 313 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hajjar, J. Schumpert, V. Hirth, D. Wieland, and G. P. Eleazer The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M414 - 418. [Abstract] [Full Text] |
||||
![]() |
L. Gasparini, G. K. Gouras, R. Wang, R. S. Gross, M. F. Beal, P. Greengard, and H. Xu Stimulation of {beta}-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal {beta}-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling J. Neurosci., April 15, 2001; 21(8): 2561 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Banks, S. A. Farr, and J. E. Morley Permeability of the Blood-Brain Barrier to Albumin and Insulin in the Young and Aged SAMP8 Mouse J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2000; 55(12): 601B - 606. [Abstract] [Full Text] |
||||
![]() |
S. Kalmijn, D. Foley, L. White, C. M. Burchfiel, J. D. Curb, H. Petrovitch, G. W. Ross, R. J. Havlik, and L. J. Launer Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men : The Honolulu-Asia Aging Study Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2255 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vekrellis, Z. Ye, W. Q. Qiu, D. Walsh, D. Hartley, V. Chesneau, M. R. Rosner, and D. J. Selkoe Neurons Regulate Extracellular Levels of Amyloid beta -Protein via Proteolysis by Insulin-Degrading Enzyme J. Neurosci., March 1, 2000; 20(5): 1657 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Bennett Diabetes and Change in Cognitive Function Arch Intern Med, January 24, 2000; 160(2): 141 - 143. [Full Text] [PDF] |
||||
![]() |
W. Zhao, H. Chen, H. Xu, E. Moore, N. Meiri, M. J. Quon, and D. L. Alkon Brain Insulin Receptors and Spatial Memory. CORRELATED CHANGES IN GENE EXPRESSION, TYROSINE PHOSPHORYLATION, AND SIGNALING MOLECULES IN THE HIPPOCAMPUS OF WATER MAZE TRAINED RATS J. Biol. Chem., December 3, 1999; 274(49): 34893 - 34902. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Craft, S. Asthana, J. W. Newcomer, C. W. Wilkinson, I. T. Matos, L. D. Baker, M. Cherrier, C. Lofgreen, S. Latendresse, A. Petrova, et al. Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose Arch Gen Psychiatry, December 1, 1999; 56(12): 1135 - 1140. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |